TITAN PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.7 USD | -0.07% |
|
-4.42% | -18.79% |
| 04-01 | Titan Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 01-26 | Titan Pharmaceuticals Regains Compliance With Nasdaq Listing Rule | MT |
Chart calendar Titan Pharmaceuticals, Inc.
8c5d455d9312bea44c8b.c7QcV1rGdO2hDJ3QlNjcatYaFraOkyq35V5TxUirj14.MflOBxaUH6vlPtOo-auzGZJZeM-3xUzhjxhhjxng-h0h-E5hHJwbocdB0A~5c457cff942791e049ca095afa6e931c
Past events on Titan Pharmaceuticals, Inc.
| 08/01/2024 | Reverse Split: 1 of 20 |
| 27/12/2023 14:00 | Extraordinary Shareholders Meeting |
| 29/06/2023 14:00 | Annual General Meeting |
| 13/11/2022 | Q3 2022 Earnings Release |
| 15/08/2022 17:00 | Extraordinary Shareholders Meeting |
| 30/12/2021 17:00 | Annual General Meeting |
| 14/11/2021 | Q3 2021 Earnings Release |
| 07/11/2021 | Society for Neuroscience Meeting |
| 15/08/2021 | Interim 2021 Earnings Release |
| 30/03/2021 | FY 2020 Earnings Release |
| 29/12/2020 | Annual General Meeting |
| 29/11/2020 | Extraordinary Shareholders Meeting |
| 16/11/2020 17:00 | Q3 2020 Earnings Call |
| 16/11/2020 13:45 | Q3 2020 Earnings Release |
| 15/11/2020 | Extraordinary Shareholders Meeting |
| 30/08/2020 | Extraordinary Shareholders Meeting |
| 14/08/2020 17:00 | Interim 2020 Earnings Call |
| 14/08/2020 13:45 | Interim 2020 Earnings Release |
| 29/06/2020 | Extraordinary Shareholders Meeting |
| 15/05/2020 17:00 | Q1 2020 Earnings Call |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 |
|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 3,61 3,32 8.7% | 4,84 3,88 24.66% | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -16,8 -17,1 1.65% | -7,35 -17,6 58.29% | 0,00 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -16,5 -16,7 1.22% | -7,41 -19,5 62.01% | 0,00 |
|
Net income Million USD | Released Forecast Spread | -16,5 -16,7 1.22% | -18,2 -19,5 6.43% | -8,78 |
|
EPS USD | Released Forecast Spread | -432 -426 -1.41% | -96,6 -125 22.84% | -18,0 |
| Announcement Date | 30/03/20 | 31/03/21 | 25/03/22 |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 |
|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,15 0,00 - | 0,10 0,00 - | |
|
EBIT Million USD | Released Forecast Spread | -2,44 -2,75 11.2% | -2,64 -2,85 7.26% | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -2,46 -2,75 10.47% | -2,64 -2,85 7.44% | |
|
Net income Million USD | Released Forecast Spread | -2,54 | -2,46 -2,75 10.47% | -2,64 -2,85 7.44% |
|
EPS USD | Released Forecast Spread | -4,80 | -3,60 -5,20 30.77% | -3,60 -4,20 14.29% |
| Announcement Date | 16/05/22 | 11/08/22 | 14/11/22 |
More events
Past sector events for Titan Pharmaceuticals, Inc.
| Today | BAUSCH HEALTH COMPANIES INC.: Q1 2024 Earnings Release |
| Today | AMGEN INC.: Q1 2024 Earnings Release |
| 01/05/2024 21:05 | CORCEPT THERAPEUTICS INCORPORATED: Q1 2024 Earnings Release |
| 01/05/2024 21:05 | JAZZ PHARMACEUTICALS PLC: Q1 2024 Earnings Release |
| 01/05/2024 11:45 | PFIZER, INC.: Q1 2024 Earnings Release |
| 01/05/2024 08:00 | HALEON PLC: Q1 2024 Sales and Revenue Release - Trading Statement |
| 01/05/2024 07:00 | GSK PLC: Q1 2024 Earnings Release |
| 30/04/2024 | INNOVIVA, INC.: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 | PACIRA BIOSCIENCES, INC.: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 | EYEPOINT PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
Quarterly earnings - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- TTNP Stock
- Calendar Titan Pharmaceuticals, Inc.
